MedPath
NMPA Approval

Deferasirox Dispersible Tablets

国药准字HJ20210081

December 14, 2021

Drug Information

地拉罗司分散片

片剂

250mg

化学药品

December 14, 2021

December 13, 2026

Company Information

Applicant Company

Formulations Division, Unit-II, Sy.No.1277 & 1319 to 1324, Nandigama (Village & Mandal) Rangareddy District - 509228, Telangana, India.

Manufacturing Company

Formulations Division, Unit-II, Sy.No.1277 & 1319 to 1324, Nandigama (Village & Mandal) Rangareddy District -509228, Telangana, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地拉罗司分散片 - NMPA 批准文号 | MedPath